Company
Every investor coverage indicates participated in a round Western Pacific Measles and Rubella Regional Verification Commission raised.
Companies Western Pacific Measles and Rubella Regional Verification Commission acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Western Pacific Measles and Rubella Regional Verification Commission. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas received a Gates Foundation grant to run first-in-human trials of its microneedle patch vaccine for measles and rubella, building on an earlier preclinical grant from the same funder.